DPC-082

Details

Stereochemistry	ABSOLUTE
Molecular Formula	C14H11F5N2O
Molecular Weight	318.242
Optical Activity	UNSPECIFIED
Defined Stereocenters	1 / 1
E/Z Centers	1
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

FC1=C(F)C2=C(NC(=O)N[C@]2(\C=C\C3CC3)C(F)(F)F)C=C1

InChI

InChIKey=JUCDJPCFPITYRP-GFUIURDCSA-N

InChI=1S/C14H11F5N2O/c15-8-3-4-9-10(11(8)16)13(14(17,18)19,21-12(22)20-9)6-5-7-1-2-7/h3-7H,1-2H2,(H2,20,21,22)/b6-5+/t13-/m0/s1

HIDE SMILES / InChI

Molecular Formula	C14H11F5N2O
Molecular Weight	318.242
Charge	0
Count

Stereochemistry	ABSOLUTE
Additional Stereochemistry	No
Defined Stereocenters	1 / 1
E/Z Centers	1
Optical Activity	UNSPECIFIED

Approval Year

PubMed

Title	Date	PubMed
Potency of nonnucleoside reverse transcriptase inhibitors (NNRTIs) used in combination with other human immunodeficiency virus NNRTIs, NRTIs, or protease inhibitors.	2002-06	12019069
Inhibition of clinically relevant mutant variants of HIV-1 by quinazolinone non-nucleoside reverse transcriptase inhibitors.	2000-05-18	10821714
Expanded-spectrum nonnucleoside reverse transcriptase inhibitors inhibit clinically relevant mutant variants of human immunodeficiency virus type 1.	1999-12	10582878

Substance Class	Chemical Created by `admin` on `Mon Mar 31 23:08:55 GMT 2025` Edited by `admin` on `Mon Mar 31 23:08:55 GMT 2025`
Record UNII	NJZ3VH3QFS
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

(4S)-4-((E)-2-CYCLOPROPYLVINYL)-5,6-DIFLUORO-4-(TRIFLUOROMETHYL)-1,3-DIHYDROQUINAZOLIN-2-ONE

Preferred Name

English

DPC-082

Code

English

DPC 082

Code

English

2(1H)-QUINAZOLINONE, 4-((1E)-2-CYCLOPROPYLETHENYL)-5,6-DIFLUORO-3,4-DIHYDRO-4-(TRIFLUOROMETHYL)-, (4S)-

Systematic Name

English

Code System Code Type Description

CAS

214287-98-6

Created by admin on Mon Mar 31 23:08:55 GMT 2025 , Edited by admin on Mon Mar 31 23:08:55 GMT 2025

PRIMARY

FDA UNII

NJZ3VH3QFS

Created by admin on Mon Mar 31 23:08:55 GMT 2025 , Edited by admin on Mon Mar 31 23:08:55 GMT 2025

PRIMARY

MANUFACTURER PRODUCT INFORMATION

DPC-082

Created by admin on Mon Mar 31 23:08:55 GMT 2025 , Edited by admin on Mon Mar 31 23:08:55 GMT 2025

PRIMARY

PUBCHEM

6451134

Created by admin on Mon Mar 31 23:08:55 GMT 2025 , Edited by admin on Mon Mar 31 23:08:55 GMT 2025

PRIMARY

Related Record Type Details


					NJZ3VH3QFS

DPC-082

ACTIVE MOIETY

Comments:

Development of DPC-082 continued since it possessed excellent intrinsic potency against the K103N-L100I mutant.